Thus, reduced SDF-1 secretion by prostate cancer cells after depletion of platelet SCF could result in diminished mPC3 tumor growth due to inhibition of angiogenesis through effects on the SDF-1/CXCR4 pathway. The gene discussed is CXCR4; the disease is prostate cancer.